Charles Schwab Investment Management Inc Stoke Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 316,134 shares of STOK stock, worth $3.63 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

316,134

Previous 289,264 9.29%

Holding current value

$3.63 Million

Previous $3.91 Million 0.56%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$12.24 - $15.92 $328,888 - $427,770	26,870 Added 9.29%	316,134 $3.89 Million
Q2 2024 Aug 12, 2024	BUY	$11.03 - $17.52 $730,472 - $1.16 Million	66,226 Added 29.69%	289,264 $3.91 Million
Q1 2024 May 08, 2024	BUY	$4.12 - $14.17 $73,319 - $252,169	17,796 Added 8.67%	223,038 $3.01 Million
Q4 2023 Feb 06, 2024	SELL	$3.37 - $5.4 $40,766 - $65,323	-12,097 Reduced 5.57%	205,242 $1.08 Million
Q3 2023 Nov 08, 2023	BUY	$3.78 - $11.99 $39,493 - $125,271	10,448 Added 5.05%	217,339 $856,000
Q2 2023 Aug 09, 2023	BUY	$7.93 - $13.82 $342,385 - $596,692	43,176 Added 26.37%	206,891 $2.2 Million
Q1 2023 May 11, 2023	SELL	$7.65 - $10.38 $8,774 - $11,905	-1,147 Reduced 0.7%	163,715 $1.36 Million
Q4 2022 Feb 13, 2023	BUY	$7.07 - $15.69 $18,502 - $41,060	2,617 Added 1.61%	164,862 $1.52 Million
Q3 2022 Nov 14, 2022	SELL	$12.56 - $22.53 $42,390 - $76,038	-3,375 Reduced 2.04%	162,245 $2.08 Million
Q2 2022 Aug 15, 2022	BUY	$10.36 - $23.93 $154,239 - $356,269	14,888 Added 9.88%	165,620 $2.19 Million
Q1 2022 May 13, 2022	BUY	$17.19 - $26.1 $50,744 - $77,047	2,952 Added 2.0%	150,732 $3.17 Million
Q4 2021 Feb 11, 2022	BUY	$18.11 - $30.72 $32,290 - $54,773	1,783 Added 1.22%	147,780 $3.55 Million
Q3 2021 Nov 16, 2021	BUY	$23.65 - $34.44 $221,718 - $322,875	9,375 Added 6.86%	145,997 $3.72 Million
Q2 2021 Aug 16, 2021	BUY	$30.53 - $41.09 $435,418 - $586,025	14,262 Added 11.66%	136,622 $4.6 Million
Q1 2021 May 17, 2021	BUY	$36.08 - $69.81 $229,577 - $444,201	6,363 Added 5.49%	122,360 $4.75 Million
Q4 2020 Feb 16, 2021	BUY	$33.62 - $61.93 $747,641 - $1.38 Million	22,238 Added 23.72%	115,997 $7.18 Million
Q3 2020 Nov 13, 2020	BUY	$22.23 - $37.48 $663,965 - $1.12 Million	29,868 Added 46.75%	93,759 $3.14 Million
Q2 2020 Aug 14, 2020	SELL	$20.26 - $29.73 $131,933 - $193,601	-6,512 Reduced 9.25%	63,891 $1.52 Million
Q1 2020 May 15, 2020	BUY	$16.8 - $34.15 $294,050 - $597,727	17,503 Added 33.09%	70,403 $1.61 Million
Q4 2019 Feb 07, 2020	BUY	$20.01 - $30.79 $10,925 - $16,811	546 Added 1.04%	52,900 $1.5 Million
Q3 2019 Nov 08, 2019	BUY	$20.53 - $37.72 $1.07 Million - $1.97 Million	52,354 New	52,354 $1.13 Million

Others Institutions Holding STOK

# of Institutions

128

Shares Held

57.6M

Call Options Held

9.3K

Put Options Held

35.2K

View Full List

About Stoke Therapeutics, Inc.

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $453M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

More about STOK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Stoke Therapeutics, Inc. Transaction History